CytoMed Therapeutics OverviewCytoMed Therapeutics Net Income
Profitability analysis for GDTC.
Quarterly Net Income
-$1.35M
↓ 24.99% YoY
As of Dec 2025
Annual Net Income (TTM)
-$4.14M
↑ 23.59% YoY
Trailing 12 months ending Dec 2025
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...